Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Neuren Pharmaceuticals Limited has announced that Milford Asset Management Limited ceased to be a substantial holder in the company. The financial activity involved the selling of 9,003,256 fully paid ordinary shares for a total consideration of $131,556,267.17 and the buying of 8,499,600 shares for $132,031,317.82, between December 2, 2022, and July 17, 2024.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.
